Oxidien Pharmaceuticals, LLC Press Releases - EIN Presswire

Published on February 18, 2021 - 14:06 GMT

Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board

GAINESVILLE, FL, USA, February 18, 2021 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced two additions to …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 23, 2020 - 13:00 GMT

Oxidien Pharmaceuticals Selected as Winner of Buzz of BIO in Early Stage Entrepreneur Category

Recognized as Early Stage Company with Ground-breaking Technology GAINESVILLE, FL, USA, September 23, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 10, 2020 - 13:00 GMT

Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate

A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study Using a Proprietary Orally Administered Oxalate Decarboxylase (OxDC) GAINESVILLE, FLA, USA, September 10, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on July 9, 2020 - 14:00 GMT

OXIDIEN PHARMACEUTICALS ANNOUNCE ADDITION TO SCIENTIFIC AND MEDICAL ADVISORY BOARD

GAINESVILLE, FL, USA, July 9, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced three additions to …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 26, 2020 - 11:59 GMT

Oxidien Pharmaceuticals Receives High Recognition at RESI Conference in Partnership with Women In Bio

Innovation Challenge Top Three and Women In Bio Finalist GAINESVILLE, FL, USA, June 26, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney disease by treating secondary hyperoxaluria, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 6, 2020 - 14:00 GMT

OXIDIEN PHARMACEUTICALS TO PRESENT AT THE 2020 BIO CEO & INVESTOR CONFERENCE

GAINESVILLE, FL, US, February 6, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced that it will …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 6, 2020 - 14:00 GMT

OXIDIEN PHARMACEUTICALS TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

GAINESVILLE, FL, US, January 6, 2020 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney disease indication, today announced that it will present at …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on December 19, 2019 - 13:00 GMT

Oxidien Pharmaceuticals Announces Favorable Response from FDA on Proposed Development Plan

Proceeds with Development of Lead Candidate to Address Unmet Need in Kidney Disease GAINESVILLE, FL, US, December 19, 2019 /⁨EINPresswire.com⁩/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...